116 related articles for article (PubMed ID: 4335641)
1. Effect of local radiotherapy on the antibody levels against EBV-induced early and capsid antigens (EA and VCA) in patients with certain malignant tumours.
Einhorn N; Henle G; Henle W; Klein G; Clifford P
Int J Cancer; 1972 Jan; 9(1):182-92. PubMed ID: 4335641
[No Abstract] [Full Text] [Related]
2. Effect of local radiotherapy on the level of EBV-associated membrane-reactive antibodies in the sera of patients with certain malignant tumors.
Einhorn N
Cancer; 1972 Mar; 29(3):714-23. PubMed ID: 4551307
[No Abstract] [Full Text] [Related]
3. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
Gunvén P; Klein G; Henle G; Henle W; Clifford P
Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
[No Abstract] [Full Text] [Related]
4. Increase in antibody titer against the EBV-associated membrane antigen complex in Burkitt's lymphoma and nasopharyngeal carcinoma after local irradiation.
Einhorn N; Klein G; Clifford P
Cancer; 1970 Nov; 26(5):1013-21. PubMed ID: 4920396
[No Abstract] [Full Text] [Related]
5. EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions.
De Schryver A; Klein G; Henle G; Henle W; Cameron HM; Santesson L; Clifford P
Int J Cancer; 1972 Mar; 9(2):353-64. PubMed ID: 4339412
[No Abstract] [Full Text] [Related]
6. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
Klein G; Dombos L; Gothoskar B
Int J Cancer; 1972 Jul; 10(1):44-57. PubMed ID: 4122458
[No Abstract] [Full Text] [Related]
7. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
Henle G; Henle W
Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
[TBL] [Abstract][Full Text] [Related]
8. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma.
Banatvala JE; Best JM; Waller DK
Lancet; 1972 Jun; 1(7762):1205-8. PubMed ID: 4113190
[No Abstract] [Full Text] [Related]
10. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease.
Bardy B; Morinet F; Pérol Y
Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178
[TBL] [Abstract][Full Text] [Related]
11. The EB virus.
Epstein MA; Achong BG
Annu Rev Microbiol; 1973; 27():413-36. PubMed ID: 4356531
[No Abstract] [Full Text] [Related]
12. Cellular reactions against Burkitt Lymphoma cells. I. Colony inhibition with effector cells from patients with Burkitt's lymphoma.
Hewetson JF; Golub SH; Klien G; Singh S
Int J Cancer; 1972 Jul; 10(1):142-9. PubMed ID: 4350508
[No Abstract] [Full Text] [Related]
13. Virus-induced antigens - a review.
Klein G
IARC Sci Publ (1971); 1975; (11 Pt 1):293-308. PubMed ID: 190131
[No Abstract] [Full Text] [Related]
14. Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma.
Inoue M; Klein G
Clin Exp Immunol; 1970 Jul; 7(1):39-50. PubMed ID: 4320551
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups.
Lin TM; Yang CS; Chiou JF; Tu SM; Chen TY; Tu YC; Lin PJ; Kawamura A; Hirayama T
Am J Epidemiol; 1977 Oct; 106(4):336-9. PubMed ID: 199059
[TBL] [Abstract][Full Text] [Related]
16. Increased antibody to herpes simplex virus in patients with nasopharyngeal cancer.
Palmer EL; Feorino PM; Martin ML
J Infect Dis; 1972 Aug; 126(2):186-8. PubMed ID: 4340927
[No Abstract] [Full Text] [Related]
17. Preliminary note. Identity of a herpesvirus antigen from Burkitt lymphoma of man and the Lucké adenocarcinoma of frogs.
Fink MA; King GS; Mizell M
J Natl Cancer Inst; 1968 Dec; 41(6):1477-8. PubMed ID: 4302580
[No Abstract] [Full Text] [Related]
18. An immunofluorescence technique with counterstain on fixed cells for the detection of antibodies to human herpesviruses; antibody patterns in patients with Hodgkin's disease and nasopharyngeal carcinoma.
Hilgers F; Hilgers J
Intervirology; 1976; 7(6):309-27. PubMed ID: 67099
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr-virus nuclear antigen.
Vonka V; Hirsch I
Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
[No Abstract] [Full Text] [Related]
20. Seroepidemiological studies on carcinoma of the nasopharynx.
Lin TM; Yang CS; Chiou JF; Tu SM; Lin CC; Liu CH; Chen KP; Ito Y; Kawamura A; Hirayama T
Cancer Res; 1973 Nov; 33(11):2603-8. PubMed ID: 4355974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
